TUMOR GROWTH RATES ARE ASSOCIATED WITH CLINICAL OUTCOMES IN VIRAL ETIOLOGIES OF HEPATOCELLULAR CARCINOMA BUT NOT IN NON-ALCOHOLIC FATTY LIVER DISEASE

被引:0
|
作者
Benhammou, Jihane N. [1 ]
Lin, Jonathan [2 ]
Aby, Elizabeth S. [3 ]
Markovic, Daniela [4 ]
Tong, Myron J. [5 ,6 ]
机构
[1] Univ Calif Los Angeles, Vache & Tamar Manoukian Div Digest Dis, Los Angeles, CA USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Digest Dis, Los Angeles, CA 90024 USA
[3] Univ Minnesota, Div Gastroenterol & Hepatol, Minneapolis, MN 55455 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90024 USA
[5] Univ Calif Los Angeles, Pfleger Liver Inst, Los Angeles, CA USA
[6] Huntington Med Res Inst Liver Ctr, Pasadena, CA USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1080
引用
收藏
页码:656A / 656A
页数:1
相关论文
共 50 条
  • [31] Hepatocellular carcinoma in non-alcoholic fatty liver disease from a clinical and public health perspective
    Antonio Diaz, Luis
    Arrese, Marco
    Pablo Arab, Juan
    HEPATOBILIARY SURGERY AND NUTRITION, 2022,
  • [32] Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease
    Than, Nwe Ni
    Ghazanfar, Anwar
    Hodson, James
    Tehami, Nadeem
    Coldham, Chris
    Mergental, Hynek
    Manas, Derek
    Shah, Tahir
    Newsome, Philip N.
    Reeves, Helen
    Shetty, Shishir
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2017, 110 (02) : 73 - 81
  • [33] Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover
    Simon, Jorge
    Ouro, Alberto
    Ala-Ibanibo, Lolia
    Presa, Natalia
    Cardoso Delgado, Teresa
    Luz Martinez-Chantar, Maria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (01)
  • [34] Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges
    Teng, Yu-Xian
    Xie, Si
    Guo, Ping-Ping
    Deng, Zhu-Jian
    Zhang, Zi-Yi
    Gao, Wei
    Zhang, Wan-Guang
    Zhong, Jian-Hong
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (05) : 955 - 964
  • [35] Systemic treatment of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease
    Rzeniewicz, Karolina
    Sharma, Rohini
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2024, 15 (11):
  • [36] Ultrasonography in surveillance for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
    Hydes, Theresa J.
    Cuthbertson, Daniel J.
    Palmer, Daniel H.
    Elshaarawy, Omar
    Johnson, Philip J.
    Fernando, Rashika
    Cross, Timothy J.
    HEPATOMA RESEARCH, 2023, 9
  • [37] Epidemiology of non-alcoholic fatty liver disease and risk of hepatocellular carcinoma progression
    Thandra, Krishna Chaitanya
    Barsouk, Adam
    Saginala, Kalyan
    Aluru, John Sukumar
    Rawla, Prashanth
    Barsouk, Alexander
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 6 (04) : 289 - 294
  • [38] PREDICTORS OF THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
    Lee, Jae Seung
    Sinn, Dong Hyun
    Lee, Hye Won
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Lee, Jung Il
    Kim, Seung Up
    HEPATOLOGY, 2021, 74 : 978A - 979A
  • [39] Risk Stratification for Hepatocellular Carcinoma in Patients with Non-alcoholic Fatty Liver Disease
    Truong E.
    Han C.
    Muthiah M.
    Noureddin M.
    Current Hepatology Reports, 2023, 22 (1) : 1 - 8
  • [40] Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver disease
    Cai, Changzhou
    Song, Xin
    Yu, Chaohui
    CANCER BIOMARKERS, 2020, 29 (01) : 69 - 78